XSpray Pharma AB (STU:6XP) Short-Term Debt : €8.35 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is XSpray Pharma AB Short-Term Debt?

XSpray Pharma AB's Short-Term Debt for the quarter that ended in Dec. 2024 was €8.35 Mil.

XSpray Pharma AB's quarterly Short-Term Debt stayed the same from Jun. 2024 (€0.00 Mil) to Sep. 2024 (€0.00 Mil) but then increased from Sep. 2024 (€0.00 Mil) to Dec. 2024 (€8.35 Mil).

XSpray Pharma AB's annual Short-Term Debt stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€8.35 Mil).

XSpray Pharma AB Short-Term Debt Historical Data

The historical data trend for XSpray Pharma AB's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Short-Term Debt Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

8.35

XSpray Pharma AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															-	-	-	-	8.35

XSpray Pharma AB Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

XSpray Pharma AB Short-Term Debt Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (STU:6XP) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

XSPRAY:Sweden 0GHZ:UK

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and XS00Y.

XSpray Pharma AB Headlines

No Headlines